H. Lundbeck
CPSE:HLUN B Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 14 Fair Values set on narratives written by author
WA
Consensus Narrative from 11 Analysts
Vyepti's Asian Triumph And Pipeline Advancements Ignite Strong Revenue Growth
Key Takeaways Strong growth of strategic brands, especially Vyepti and Rexulti, is expected to drive substantial revenue increase in Asian and emerging markets. Anticipated regulatory approvals and drug pipeline advancements will positively impact future earnings and long-term growth potential.
View narrativeDKK 51.95
FV
23.5% undervalued intrinsic discount5.82%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
24 days ago author updated this narrative